Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
Duke University · Duke Medical Center · +3 more institutions
Abstract
There are currently few treatment options for pulmonary fibrosis. Innovations may come from a better understanding of the cellular origin of the characteristic fibrotic lesions. We have analyzed normal and fibrotic mouse and human lungs by confocal microscopy to define stromal cell populations with respect to several commonly used markers. In both species, we observed unexpected heterogeneity of stromal cells. These include numerous cells with molecular and morphological characteristics of pericytes, implicated as a source of myofibroblasts in other fibrotic tissues. We used mouse genetic tools to follow the fates of specific cell types in the bleomcyin-induced model of pulmonary fibrosis. Using inducible…
Citation impact
- FWCI
- 46.42
- Percentile
- 100%
- References
- 52
Authors
8- JRJason R. RockCorresponding
Duke University, Duke Medical Center, Duke University Hospital, Institute of Cell Biology
- CEChristina E. Barkauskas
Pulmonary and Allergy Associates
- MJMichael J. Cronce
Pulmonary and Allergy Associates
- YXYan Xue
Institute of Cell Biology
- JRJeffrey R. Harris
Duke University, Duke Medical Center
Topics & keywords
- Myofibroblast
- Stromal cell
- Biology
- Mesenchymal stem cell
- Pericyte
- Pulmonary fibrosis
- Cell type
- Pathology